Brief: Biotec Pharmacon Q3 EBITDA loss widens to NOK 7.3 mln
Oct 19 (Reuters) - BIOTEC PHARMACON ASA BIOTEC.OL
* Q3 REVENUE NOK 14.4 MILLION VERSUS NOK 21.1 MILLION YEAR
AGO
* Q3 EBITDA LOSS NOK 7.3 MILLION VERSUS LOSS NOK 5.9
MILLION YEAR AGO
Source text for Eikon: ID:nWkr52x7B0
Further company coverage: BIOTEC.OL
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))